(Updated, 6:15 p.m.)
Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC.
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth.
By Michelle Fay Cortez and John Lauerman Bloomberg News
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities.
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases.